Not exactly sure what to make of this? Here are the first thoughts that jumped in my head, what do you guys think?
Positives
-They will be seeking handhelds, which to my understanding we have the best product. The new handheld should also be ready by the time they start accepting products in June.
-There is a concerted effort to make an easier process for procuring ETD devices, this should only bode well for us.
-They will be soon gathering info for a handheld narcotic device, which our handheld can double as.
-They will be moving away from doing IDIQ's for ETD, meaning our IDIQ(if it stands, will be the last). I see this as a positive, because it means they cannot offer any IDIQ's to our competitors. Competitors next chance for procurement will not be til FY '16.
Negatives
-If the appeal was won by Morpho's, we also wouldn't be able to be procured until FY '16.
-Only 12 months for testing of new products? This could let competitors jump in a little quicker